Simon Frost currently serves as Director of both Cure AHC, and Hope For Annabel, charities dedicated to finding viable genetic therapies for alternating hemiplegia of childhood (AHC). Simon’s daughter Annabel has a de novo mutation in ATP1A3 – the gene most commonly associated with AHC.
Simon is currently the CEO of Tiber Capital Group – a real estate investment firm. He has previously served as the Chief Investment Officer of Greencourt Capital Group, Co-Founder and Chief Financial Officer of The American Home, President and Chief Operating Officer of Key Properties, and the Chief Financial Officer of Goal Financial.
Simon holds bachelor’s and master’s degrees in economics from Cambridge University in England, and a bachelor’s degree in finance from the University of South Africa.